Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ MORE

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ MORE

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ MORE

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ MORE

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

LINKEDIN PAGE

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

READ NOW

Best Education For Design

Rimply dummy text of the printing and typesetting industry
lorem Ipsum has been the industry's standard

START A COURSE

WATCH THE VIDEO

Welcome To IRDiRC

Our vision: Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention

Goal 1

All patients coming to medical attention with a suspected rare disease will be diagnosed within one year if their disorder is known in the medical literature; all currently undiagnosable individuals will enter a globally coordinated diagnostic and research pipeline

Goal 2

1000 new therapies for rare diseases will be approved, the majority of which will focus on diseases without approved options

Goal 3

Methodologies will be developed to assess the impact of diagnoses and therapies on rare disease patients

Watch Our Presentation Video

Latest News

Newborn screening in Mexico and Latin America: present and future

June 24, 2024

IRDiRC announces the launch of a new paper on “Newborn screening in Mexico…

RARE ON AIR – Ayça Şahin’s story

June 24, 2024

Listen now to EURORDIS RARE ON AIR latest episode, where Julien Poulain (Communication…

Announcement of FDA Office of Orphan Products Grant Funding Opportunity

June 24, 2024

The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is…